BlueCrest Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6,364	Closed	-$345K	–	147
2024 Q1	$345K	Sell	6,364 -52,701	-89%	-$2.68M	0.08%	183
2023 Q4	$3.03M	Buy	59,065 +40,501	+218%	+$2.13M	0.51%	130
2023 Q3	$1.08M	Buy	+18,564	New	+$1.14M	0.17%	175
2019 Q4	–	Sell	-5,766	Closed	-$292K	–	408
2019 Q3	$292K	Buy	+5,766	New	+$271K	0.02%	371
2019 Q2	–	Hold	0	–	–	–	483
2019 Q1	–	Sell	-13,153	Closed	-$655K	–	1183
2018 Q4	$684K	Sell	13,153 -1,616	-11%	-$86.8K	0.04%	282
2018 Q3	$917K	Buy	14,769 +1,285	+10%	+$76.3K	0.03%	478
2018 Q2	$746K	Buy	+13,484	New	+$728K	0.03%	641
2017 Q3	–	Sell	-10,931	Closed	-$609K	–	858
2017 Q2	$609K	Buy	+10,931	New	+$595K	0.03%	551
2017 Q1	–	Sell	-28,500	Closed	-$1.67M	–	751
2016 Q4	$1.67M	Buy	+28,500	New	+$1.56M	0.1%	283
2016 Q1	–	Sell	-4,613	Closed	-$317K	–	794
2015 Q4	$317K	Buy	+4,613	New	+$305K	0.02%	723